Kite Pharma (KITE) on Track to Submit KITE-C19 BLA This Year - Investor Day

October 18, 2016 2:58 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Kite Pharma (NASDAQ: KITE) says it is still on track to submit a Biologics License Application (BLA) on KITE-C19 this year, according to Bloomberg, citing today's company webcast.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk

Add Your Comment